| PARK3 |
|
Parkinson disease 3 (autosomal dominant, Lewy body)
|
|
|
0.821 |
0.038 |
| USP40 |
Q9NVE5
|
ubiquitin specific peptidase 40
|
Enzyme
|
1.2E-25 |
0.931 |
0.038 |
| PARK10 |
|
Parkinson disease 10 (susceptibility)
|
|
|
0.890 |
0.038 |
| VPS29 |
Q9UBQ0
|
VPS29 retromer complex component
|
Transporter
|
0.75 |
0.890 |
0.038 |
| MIDN |
Q504T8
|
midnolin
|
|
0.18 |
0.890 |
0.038 |
| PARK16 |
|
Parkinson disease 16 (susceptibility)
|
|
|
0.861 |
0.077 |
| TMEM230 |
Q96A57
|
transmembrane protein 230
|
|
1.8E-04 |
0.769 |
0.115 |
| LRRK1 |
Q38SD2
|
leucine rich repeat kinase 1
|
Kinase
|
4.5E-10 |
0.780 |
0.115 |
| CYP20A1 |
Q6UW02
|
cytochrome P450 family 20 subfamily A member 1
|
|
8.9E-17 |
0.821 |
0.154 |
| USP24 |
Q9UPU5
|
ubiquitin specific peptidase 24
|
|
1.00 |
0.760 |
0.231 |
| FRA6E |
|
fragile site, aphidicolin type, common, fra(6)(q26)
|
|
|
0.792 |
0.231 |
| TMEM132E |
Q6IEE7
|
transmembrane protein 132E
|
|
4.5E-05 |
0.805 |
0.231 |
| GIGYF2 |
Q6Y7W6
|
GRB10 interacting GYF protein 2
|
|
1.00 |
0.711 |
0.269 |
| ELAVL4 |
P26378
|
ELAV like RNA binding protein 4
|
|
0.91 |
0.682 |
0.269 |
| MIR302C |
|
microRNA 302c
|
|
|
0.711 |
0.269 |
| SFSWAP |
Q12872
|
splicing factor SWAP
|
Nucleic acid binding
|
1.00 |
0.780 |
0.269 |
| BED |
|
Bornholm eye disease
|
|
|
0.729 |
0.308 |
| TMEM98 |
Q9Y2Y6
|
transmembrane protein 98
|
|
1.2E-02 |
0.736 |
0.308 |
| RHOT1 |
Q8IXI2
|
ras homolog family member T1
|
Enzyme modulator
|
0.80 |
0.722 |
0.308 |
| GLIS1 |
Q8NBF1
|
GLIS family zinc finger 1
|
|
3.9E-02 |
0.751 |
0.308 |
| B3GALT4 |
O96024
|
beta-1,3-galactosyltransferase 4
|
Enzyme
|
3.0E-02 |
0.792 |
0.308 |
| SARM1 |
Q6SZW1
|
sterile alpha and TIR motif containing 1
|
|
1.7E-10 |
0.682 |
0.346 |
| RAD23A |
P54725
|
RAD23 homolog A, nucleotide excision repair protein
|
Nucleic acid binding
|
0.18 |
0.769 |
0.346 |
| LINGO1 |
Q96FE5
|
leucine rich repeat and Ig domain containing 1
|
Receptor
|
0.99 |
0.682 |
0.385 |
| ANO3 |
Q9BYT9
|
anoctamin 3
|
|
1.2E-17 |
0.716 |
0.385 |